WO2003039611A1 - Methode de formation de tissu regenere normal, tissu regenere normal, et methode d'echantillonnage de la sensibilite - Google Patents

Methode de formation de tissu regenere normal, tissu regenere normal, et methode d'echantillonnage de la sensibilite Download PDF

Info

Publication number
WO2003039611A1
WO2003039611A1 PCT/JP2002/010674 JP0210674W WO03039611A1 WO 2003039611 A1 WO2003039611 A1 WO 2003039611A1 JP 0210674 W JP0210674 W JP 0210674W WO 03039611 A1 WO03039611 A1 WO 03039611A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
regenerated tissue
calibrating
normal regenerated
normal
Prior art date
Application number
PCT/JP2002/010674
Other languages
English (en)
French (fr)
Inventor
Shigekazu Nakatsugawa
Original Assignee
Japan Science And Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science And Technology Agency filed Critical Japan Science And Technology Agency
Priority to JP2003541901A priority Critical patent/JP4183619B2/ja
Priority to US10/492,688 priority patent/US8592176B2/en
Priority to EP02777835.6A priority patent/EP1444994B1/en
Priority to DK02777835.6T priority patent/DK1444994T3/da
Publication of WO2003039611A1 publication Critical patent/WO2003039611A1/ja
Priority to NO20042015A priority patent/NO20042015L/no
Priority to US14/058,885 priority patent/US9695396B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/088—Coculture with; Conditioned medium produced by cells of the nervous system neural stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/095—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells mammary cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/246—Cells of the male genital tract, non-germinal testis cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/25—Urinary tract cells, renal cells
    • C12N2502/256—Renal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PCT/JP2002/010674 2001-10-15 2002-10-15 Methode de formation de tissu regenere normal, tissu regenere normal, et methode d'echantillonnage de la sensibilite WO2003039611A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2003541901A JP4183619B2 (ja) 2001-10-15 2002-10-15 正常再生組織の形成方法と正常再生組織並びに感受性等の検定方法
US10/492,688 US8592176B2 (en) 2001-10-15 2002-10-15 Methods for forming and using a stratified structure of epithelial cells
EP02777835.6A EP1444994B1 (en) 2001-10-15 2002-10-15 Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on
DK02777835.6T DK1444994T3 (da) 2001-10-15 2002-10-15 Fremgangsmåde til dannelse af normalt regenereret væv, normalt regenereret væv, og fremgangsmåde til kalibrering af sensitivitet og lignende
NO20042015A NO20042015L (no) 2001-10-15 2004-05-14 Fremgangsmate for a danne normalt regenerert vev, det normale regenererte vevet og framgangsmaten for kalibrering av sensitivitet
US14/058,885 US9695396B2 (en) 2001-10-15 2013-10-21 Regenerated tissue comprising a stratified structure of epithelial cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-317502 2001-10-15
JP2001317502 2001-10-15

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/492,688 A-371-Of-International US8592176B2 (en) 2001-10-15 2002-10-15 Methods for forming and using a stratified structure of epithelial cells
US14/058,885 Division US9695396B2 (en) 2001-10-15 2013-10-21 Regenerated tissue comprising a stratified structure of epithelial cells

Publications (1)

Publication Number Publication Date
WO2003039611A1 true WO2003039611A1 (fr) 2003-05-15

Family

ID=19135362

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/010674 WO2003039611A1 (fr) 2001-10-15 2002-10-15 Methode de formation de tissu regenere normal, tissu regenere normal, et methode d'echantillonnage de la sensibilite

Country Status (7)

Country Link
US (2) US8592176B2 (ja)
EP (1) EP1444994B1 (ja)
JP (1) JP4183619B2 (ja)
KR (1) KR100777993B1 (ja)
DK (1) DK1444994T3 (ja)
NO (1) NO20042015L (ja)
WO (1) WO2003039611A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012501731A (ja) * 2008-09-05 2012-01-26 エシコン・インコーポレイテッド 無細胞マトリックス接着剤
JP2014502847A (ja) * 2011-01-06 2014-02-06 カプサント・ニューロテクノロジーズ・リミテッド 腫瘍細胞及び組織培養
WO2019039457A1 (ja) * 2017-08-21 2019-02-28 凸版印刷株式会社 初代培養方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876246A1 (fr) * 2004-10-12 2006-04-14 Univ Reims Champagne Ardenne Procede d'obtention d'epithelium bronchiolaire humain regenere
CN111345851B (zh) * 2020-03-13 2021-12-17 辽宁石油化工大学 一种超声评价生物多孔性材料引导组织修复过程的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016036A (en) 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
WO2000029553A1 (en) 1998-11-19 2000-05-25 Organogenesis Inc. Bioengineered tissue constructs and methods for producing and using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914032A (en) * 1985-06-06 1990-04-03 Centro De Investigation Y Estudios Avanzados Del Instituto Politecnico Nacional Process for the long-term surviving culture of hepatocytes
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
JP3488486B2 (ja) 1993-07-30 2004-01-19 藤森工業株式会社 食品の移送装置
US5695998A (en) * 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US6548058B1 (en) * 1999-07-20 2003-04-15 Epitech, S.A. Keratinocyte culture and uses thereof
JP2001211879A (ja) * 1999-11-26 2001-08-07 Menicon Co Ltd 細胞の接着および増殖方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016036A (en) 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
WO2000029553A1 (en) 1998-11-19 2000-05-25 Organogenesis Inc. Bioengineered tissue constructs and methods for producing and using them

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP1444994A4 *
SHANNON JOHN M. ET AL.: "Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cell-cell interactions", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 931, 1987, pages 143 - 156, XP002961068 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012501731A (ja) * 2008-09-05 2012-01-26 エシコン・インコーポレイテッド 無細胞マトリックス接着剤
JP2014502847A (ja) * 2011-01-06 2014-02-06 カプサント・ニューロテクノロジーズ・リミテッド 腫瘍細胞及び組織培養
WO2019039457A1 (ja) * 2017-08-21 2019-02-28 凸版印刷株式会社 初代培養方法
JPWO2019039457A1 (ja) * 2017-08-21 2020-07-30 凸版印刷株式会社 初代培養方法
JP7264814B2 (ja) 2017-08-21 2023-04-25 凸版印刷株式会社 初代培養方法
US11781115B2 (en) 2017-08-21 2023-10-10 Toppan Printing Co., Ltd. Primary culture method

Also Published As

Publication number Publication date
JP4183619B2 (ja) 2008-11-19
KR20050036855A (ko) 2005-04-20
EP1444994B1 (en) 2014-07-30
EP1444994A4 (en) 2009-07-15
DK1444994T3 (da) 2014-08-18
KR100777993B1 (ko) 2007-11-28
US8592176B2 (en) 2013-11-26
EP1444994A1 (en) 2004-08-11
US20040241837A1 (en) 2004-12-02
NO20042015L (no) 2004-07-14
US9695396B2 (en) 2017-07-04
US20140147831A1 (en) 2014-05-29
JPWO2003039611A1 (ja) 2005-02-24

Similar Documents

Publication Publication Date Title
WO2005113747A3 (de) Multizelluläre gewebe- und organkultursysteme
AU2002338667A1 (en) Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture
ATE538819T1 (de) Medizinische vorrichtungen und verfahren zu ihrer herstellung
ATE508725T1 (de) Verfahren zur herstellung von tabletten
WO2006023444A3 (en) Anti-adhesion barrier
DE59601819D1 (de) Vorrichtung zur schichtweisen herstellung eines objektes mittels lasersintern
EP1790635A3 (en) Processes for preparing amorphous fluvastatin sodium
DE60028492D1 (de) Vorrichtung zur Herstellung von Dünnfilmen
WO2003008647A3 (en) Blood assessment of injury
WO2001055297A3 (de) Dreidimensionalen matrixkörper und vorrichtung sowie verfahren zum messen von kontraktionen eines zellgewebes
DE60000018T2 (de) Elektrochemischer Prozess zur Herstellung eines Körpers mit dreidimensionaler periodischer Sruktur
EP2402752A3 (en) A method for pharmacologically profiling compounds
WO2004098537A3 (en) Activation agents on the surface of encapsulation vesicles
FR2860224B1 (fr) Solide cristallise im-12 et son procede de preparation
AU2003218804A1 (en) Hybrid grafts including biodegradable polymer supporting layer and manufacturing process thereof
WO2008063759A3 (en) A method of increasing retention, survival and proliferation of transplanted cells in vivo
AU2003207285A1 (en) High-density cell array board, process for producing the same and method of using the same
WO2003039611A1 (fr) Methode de formation de tissu regenere normal, tissu regenere normal, et methode d'echantillonnage de la sensibilite
AU6830900A (en) Method for the production of three-dimensional or flat structures
WO2006112932A3 (en) Coatings for implantable medical devices containing attractants for endothelial cells
WO2003022993A3 (en) Methods for producing ex vivo models for inflammatory disease and uses thereof
ZA200301245B (en) Method of making topographical support members for producing apertured films.
AU2002239664A1 (en) Method for drug development using individual patient response
AU2003300912A8 (en) Direct organic fuel cell proton exchange membrane and method of manufacturing the same background of the invention
WO2008074267A3 (en) Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP KR NO US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003541901

Country of ref document: JP

Ref document number: 1020047005511

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2002777835

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10492688

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002777835

Country of ref document: EP